Tag: Gift

$40 million gift to USC will expand research with CHLA

USC President Carol L. Folt and Children’s Clinic Los Angeles President and Chief Executive Officer Paul S. Viviano on Monday announced a new, $40 million partnership in biomedical study and innovation initiatives to boost health and fitness care. The endeavours are dependent on a reward to USC from the Alfred E. Mann Charities and Alfred E. Mann Basis for Biomedical Engineering.

“Today’s announcement is testament to the electrical power of relationship — involving a visionary entrepreneur’s generosity and two identified leaders in biomedical research and innovation,” Folt claimed.

Viviano also expressed his appreciation to the basis and reported that the partnership will extend and greatly enhance research chances throughout both of those institutions.

“We are grateful to the Alfred E. Mann Charities for their large motivation to supporting progressive analysis and collaboration,” Viviano said. “Our workforce members look ahead to functioning jointly with USC to make scientific discoveries to strengthen the lives of little ones — and the grown ups they will develop into.”

USC-CHLA investigation: Associates for decades

USC and CHLA have been affiliated to progress the well being of children in the county and beyond for far more than 90 a long time. CHLA is a regional and countrywide chief in supplying clinically outstanding, specialised and intricate pediatric care, reaching 1 in 3 children each year in Los Angeles County by yourself. This inclusive, compassionate and loved ones-centered clinical treatment is led by physicians who are school users of the Keck Faculty of Medicine of USC.

million gift to USC will expand research with CHLA

Al Mann was a generous supporter of the university. (Picture/Ziva Santop/Steve Cohn Pictures)

“As we rejoice this new $40 million partnership with CHLA, we also spend tribute to the late Alfred E. Mann and his visionary donation. Together, we will continue to progress biomedical analysis and innovation initiatives that goal to boost boy or girl wellness,” explained Steven Shapiro, USC senior vice president for well being affairs.

The most current present signifies the last distribution of an unique donation to USC in 1998 from Mann. About the class of 25 decades, the late inventor and entrepreneur’s present, meant for biomedical and biodevice research and advancement, grew from over $170 million to more than $230 million, presenting USC and the foundation with new opportunities to increase Mann’s legacy.

Folt envisioned the restructuring of the reward to increase health and fitness care across all phases of everyday living. In November, she announced the naming of the USC Alfred E. Mann Faculty of Pharmacy and Pharmaceutical Sciences with a $50 million endowment from the basis. In addition, she introduced the naming of the USC Viterbi College of Engineering’s Alfred E. Mann Department of Biomedical Engineering with a $35 million endowment to guidance education and scholarship.

USC Mann naming ceremony: President Carol L. Folt, Dean Vassilios Papadopoulos and Trustee Chair Suzanne Nora Johnson

USC President Carol L. Folt, USC Mann Dean Vassilios Papadopoulos and USC Trustee Chair Suzanne Nora Johnson, from remaining, pause in front of the creating sporting the pharmacy school’s new identify in February. (USC Picture/Gus Ruelas)

At a ceremony celebrating the naming of USC Mann Faculty in February, Folt mentioned Mann’s intensive history of innovations aimed at enhancing health results.

Throughout his prolonged and distinguished vocation, Mann started businesses and funded the development of solutions that revolutionized the health care subject. He also donated more than $174 million to USC towards breakthroughs for human overall health, together with the establishment of the USC Alfred E. Mann Institute, which has been instrumental in producing groundbreaking medical inventions these as the artificial retina. Mann, who died in 2016, was a member of the university’s Board of Trustees and also served on the Board of Overseers of Keck School of Drugs.

USC-CHLA investigate will increase innovation throughout the lifespan

Representatives of the Alfred E. Mann Charities authorised redistributing the present amongst numerous initiatives. With this newest distribution, the college and CHLA are collaborating to improve overall health care investigation and innovation throughout the lifespan — an work that Mann himself would have supported.

“Al was an excellent inventor who devoted himself to resourceful solutions that would strengthen and lengthen the lives of hundreds of thousands of folks,” stated Michael Dreyer, Anoosheh Bostani and Claude Mann of the Alfred E. Mann Charities. “Al would have been so touched to see that his present is now encouraging USC and Children’s Medical center Los Angeles to assist even the youngest sufferers to dwell healthier, longer lives. It is a terrific way to honor his legacy throughout generations.”

USC and CHLA will keep an function Monday evening to celebrate the new partnership, with attendees such as foundation associates, school, scientists and other supporters.

During the 2022 fiscal yr, CHLA handled additional than 700,000 individuals. As an tutorial health care middle, CHLA is the place Keck Faculty of Medication trains the subsequent generation of pediatricians and in which medical practitioners bring a research mentality to managing sicknesses.

USC and CHLA have collaborated on revolutionary mobile therapy courses to revolutionize the treatment of a wide range of ailments.

Now, the USC/CHLA Translational Cell Treatment Method is composed of 40 principal investigators with a lot more than $56 million in funding from the Countrywide Institutes of Wellness for mobile and gene treatment study. 4 initiatives have advanced to medical screening or late pre-scientific growth stages 6 much more are advancing toward medical advancement.

In January, USC and CHLA opened a new laboratory to advance early-stage investigation into lifesaving, commercially viable therapies at the USC Norris Comprehensive Most cancers Heart. The laboratory is made to manufacture mobile and gene therapies under the Food items and Drug Administration’s great manufacturing observe standards.

“The hottest present will undoubtedly strengthen the collaborative function of equally institutions,” explained Ishwar K. Puri, USC’s senior vice president for investigate and innovation.

“As acknowledged leaders in professional medical investigation, USC and CHLA deliver special and synergistic strengths,” reported Puri. “This reward makes it possible for us to nurture new collaborations to develop therapies that enhance wellness and high-quality of lifetime from childhood by means of aging.”

A lot more stories about: Children’s Medical center Los Angeles, Donors, Investigate

Roy and Diana Vagelos Institute for Biomedical Research Education Launched at Columbia University with $175 Million Gift

With the COVID-19 pandemic highlighting the critical importance of biomedical research and new questions being raised about society’s capacity to generate world-changing scientific breakthroughs1, Roy and Diana Vagelos have made a $175 million gift to Columbia University to address this need. The Vagelos Institute for Biomedical Research Education created with this gift will be home to PhD students pursuing the most creative, potentially disruptive ideas in biomedical science, and will spur the training of more physician-scientists able to translate the latest paradigm-shifting discoveries into revolutionary new methods in patient care.  

logo

The gift will enable Columbia to create a new academic model that encourages and accelerates the intellectual risk-taking needed to make historic advances in health science research. Supportive career pathways, promising stability and academic freedom, are being developed to attract more students and junior faculty to this essential endeavor. Currently in the United States, PhD students, MDs in training, residents, fellows, and early-career physician-scientists who pursue a career in basic, translational or clinical research must contend with both financial challenges and professional uncertainty2.

By directly addressing and mitigating these obstacles, the Vagelos gift seeks to create an academic research environment conducive to bold experimentation and a sustained commitment to solving longstanding medical problems. Reducing the disproportionate financial burdens that deter historically marginalized groups from pursuing a career in science is a central pillar of this program.

“The financial support provided by Roy and Diana Vagelos to Columbia has been extraordinary, and so too is the leadership they provide through the values embodied in their philanthropy,” said Katrina Armstrong, Dean of the Columbia University Vagelos College of Physicians and Surgeons, and EVP for Health and Biomedical Sciences. “The Vagelos Institute for Biomedical Research Education will have an enormous impact in harnessing the power of science to transform clinical care, and I believe we will see similar initiatives started at other university medical schools. The reward for this effort will be unprecedented strides forward in curing disease and treating illness. It’s an opportunity—and a responsibility—we must embrace.”

The largest portion of the gift—$125 million—will establish an endowment to transform the prevailing approach for funding PhD students. This will provide Columbia trainees with greater freedom to explore different interests at the start of their careers. The remaining $50 million of the gift will support aspiring physician-scientists seeking to develop expertise in both fundamental biology and clinical medicine.

An external scientific advisory board of seasoned scientists and experts in graduate biomedical education will guide the development of these programs and of the new graduate biomedical curriculum tracks. The board is tasked with ensuring that Columbia University creates the optimal environment to nurture the growth of scientists who will shape the future of medicine. The initial group of board members includes Enrique M. De La Cruz, PhD, of the Yale School of Medicine; Tracy Johnson, PhD, of UCLA; William Kaelin Jr., MD, of the Dana-Farber Cancer Institute; and Shirley M. Tilghman, PhD, of Princeton University.

“This extraordinary generosity from Roy and Diana Vagelos continues their visionary support of education at the Vagelos College of Physicians and Surgeons, which so appropriately bears their name,” said Columbia University President Lee C. Bollinger. “It also continues their trailblazing efforts to rethink and strengthen the future of science and medical education at Columbia and around the world. For all of this, and so much more, we are extremely grateful.”

Roy and Diana Vagelos have been trailblazers in rethinking and strengthening the future of science and medical education at Columbia and around the world. Together with scholarship support from countless VP&S alumni, friends, and faculty, their transformative $250 million gift in 2017 made it possible for Columbia’s medical school to become the first in the nation to offer debt-free education to students. Their leadership precipitated a national movement among medical schools to eliminate student debt. The medical school was renamed the Vagelos College of Physicians and Surgeons as a tribute to their impact. This second transformational gift reflects the couple’s remarkable generosity and their deeply held values. It builds on a shared lifetime of charitable and compassionate action, particularly in their efforts to advance science, medical education, and better health care for all. For more information about Roy and Diana Vagelos, their respective professional accomplishments, and their prior giving to Columbia, please visit this page.

“We all know that continued scientific progress is the foundation for solving our most pressing medical problems,” said Dr. Vagelos. “Diana and I each vividly recall the difference that financial support made in creating a sense of freedom and instilling the confidence to pursue our passions early in our lives. We want to give others this same freedom by removing the obstacles facing researchers and scientists in training. The larger the number of talented researchers who are able to explore areas of discovery that capture their imaginations, the greater the impact they will have in changing medicine and improving health. It is our honor to give back.”